GPRO Stock UPDATES Gopro Inc. (GPRO) 58.75 09/06/2014 11:06:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gopro Inc. (GPRO) 58.75 $GPRO

Ambarella Pegs Strong Q3 Guidance On Evolving Cameras
at Investor's Business Daily - Fri Sep 05, 11:54AM CDT
Several analysts on Friday boosted the target price for specialty chipmaker Ambarella, and the stock touched a new high after the company late Thursday gave Q3 guidance that exceeded Wall Street expectations. Ambarella (AMBA) CFO George Laplante said...

Jim Cramer's Stop Trading: GoPro Is Going Strong Into the Holidays
at The Street - Fri Sep 05, 10:13AM CDT
Cramer sees shares of GoPro getting a boost from Ambarella's earnings results, headed into the second half of 2014.

Why GoPro (GPRO) Stock Is Rising Today
at The Street - Fri Sep 05, 10:10AM CDT
GoPro (GPRO) stock is climbing in late morning trading after its supplier Ambarella (AMBA) reported strong second quarter earnings yesterday.

3 Reasons Why Apple, Inc. Should Keep This $2.5 Billion Business
Jamal Carnette, The Motley Fool - Motley Fool - Fri Sep 05, 9:43AM CDT
Apple's beleaguered iPod has seen better days, but Apple should keep the product. Source: Apple Apple 's been on a roll lately, giving investors a 1-year return of nearly 50% with the stock hovering near all-time split-adjusted highs on a per...

Ambarella Chips For GoPro Cameras Help Spur Q2 Beat
at Investor's Business Daily - Thu Sep 04, 5:52PM CDT
Ambarella, pointing to new opportunities for the wearable, security and other high-definition cameras that use its chips, late Thursday posted fiscal Q2 earnings that easily topped Wall Street expectations. Ambarella (AMBA) reported earnings per...

Why You Shouldn't be Scared by GoPro's Valuation
David Kretzmann, The Motley Fool - Motley Fool - Thu Sep 04, 2:45PM CDT
GoPro  is doing something that has never been done before: selling cameras to users with the intent of using those cameras as "capture devices" to generate content for a media network, the GoPro Network. This video transition from raw cut to final...

Stocks Open Quietly Higher; BitAuto, PVH Gain, GoPro Slumps
at Investor's Business Daily - Thu Sep 04, 9:41AM CDT
Stocks rifled higher at Thursday's open on a mix of U.S. and overseas economic news. The Nasdaq stepped out to an early lead, up 0.6%. The Dow Jones industrial average and the S&P 500 each added 0.4%. Trade was soft, down 7% on the Nasdaq and 2%...

These Skyrocketing Metrics Could be Key for GoPro
David Kretzmann, The Motley Fool - Motley Fool - Thu Sep 04, 9:06AM CDT
I recently explored the three pillars of GoPro 's growth strategy, all of which center on empowering users to generate, manage, and share their passions and experiences. GoPro sold 3.8 million of its high-definition cameras in 2013, capturing 45%...

Why GoPro (GPRO) Stock Is Down In Pre-Market Trading Today
at The Street - Thu Sep 04, 7:38AM CDT
GoPro (GPRO) stock is falling in pre-market trading following a ratings downgrade to 'neutral' from 'overweight' at JPMorgan (JPM).

3 Things to Watch for When Ambarella Reports on Thursday
Ashraf Eassa, The Motley Fool - Motley Fool - Wed Sep 03, 6:00PM CDT
This article originally appeared as part of ongoing coverage in our premium   Motley Fool Rule Breakers service ...we hope you enjoy this complimentary peek! Ambarella , a semiconductor company that develops chips that go into high-definition...

Tarena Is Rare Among Recent IPOs: It's Making Money
at Investor's Business Daily - Wed Sep 03, 4:06PM CDT
The April initial public offering Tarena International is among a small group of recent IPOs with a profitable history. Many IPOs debut with just a promise of profits. Some only recently turned profitable. Others, however, have shown progressively...

Cease-Fire News Stirs Stocks; Mobileye, GoPro Power Ahead
at Investor's Business Daily - Wed Sep 03, 9:40AM CDT
Stocks trimmed early gains Wednesday, flickering in and out of mixed trade early as global markets responded to contradictory news of a Ukraine/Russia cease-fire. The Dow Jones industrial average climbed 0.3%. The S&P 500 lodged a 0.2% gain. The...

Jim Cramer's Top Stock Picks: TWTR GPRO TSLA NFLX GNC VSI
at The Street - Wed Sep 03, 5:00AM CDT
Cramer wants GNC to buy Vitamin Shoppe while Twitter, GoPro, Tesla and Netflix will be hot commodities for fund managers this year.

Jim Cramer's 'Mad Money' Recap: The 2012 Stock Market All Over Again
at The Street - Tue Sep 02, 6:49PM CDT
Investors are dumping the industrial and technology stocks in favor of anything domestic, including health care, transportation, restaurants and entertainment, Cramer says.

GoPro Investors Can’t Ignore These 3 Key Problems
Leo Sun, The Motley Fool - Motley Fool - Tue Sep 02, 5:52PM CDT
GoPro has loomed large in headlines recently -- the company recently introduced a $60 dog harness to let canines capture video, and fans are buzzing about its upcoming HERO4 camera. Source: GoPro GoPro's stock, however, has been a divisive...

3 Hot Recent IPOs Reporting Earnings This Week
at Investor's Business Daily - Tue Sep 02, 5:14PM CDT
Three hot young stocks that began trading within the last year, including driver-assistance systems maker Mobileye, are slated to report second-quarter earnings this week. Mobileye (MBLY) -- developer of backup cameras, automatic braking and...

Why Taser May Rule Body Cameras Despite Digital Ally
at Investor's Business Daily - Tue Sep 02, 12:40PM CDT
Taser International (TASR) may be the best positioned security device maker to take advantage of a global boom in use of on-officer cameras over the next decade, a report said Tuesday. Ladenburg Thalmann initiated coverage on Taser with a buy rating...

Cramer: What's Working, What's Not
at The Street - Tue Sep 02, 11:05AM CDT
Yep, the bets for the rest of 2014 are being placed.

Thin Gains Quickly Turn Mixed; Regeneron, Staples Surge Ahead
at Investor's Business Daily - Tue Sep 02, 9:43AM CDT
Stocks opened to narrow gains but quickly slipped into tightly mixed territory in heavy trade Tuesday, despite a passel of positive economic reports. The Nasdaq rose 0.3%. The S&P 500 slipped into negative territory, then recovered to a fractional...

4 Big Stocks to Trade (or Not)
at The Street - Fri Aug 29, 1:47PM CDT
Here's how to trade some of the most active stocks on the market today.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Schouw & Co.'s Share Buy-Back Strategy for 2025

Updated Category News Views 153

Overview of Schouw & Co.'s Share Buy-Back Program Schouw & Co. has launched an exciting share buy-back initiative, aiming to enhance shareholder value significantly. This program began on May 5, 2025, and is designed to repurchase shares totaling up to DKK 120 million. This investment runs until December 31, 2025, reflecting the company's commitment to its shareholders....

Continue Reading
Schneider National Plans to Reveal Q3 2024 Earnings Soon

Updated Category News Views 45

Schneider National to Report Third Quarter 2024 Earnings Schneider National, Inc. (NYSE: SNDR), a leader in transportation and logistics services, has announced that it will release its third quarter 2024 earnings report on a future date, ahead of the market opening. This announcement is significant as it highlights the company’s continued focus on financial...

Continue Reading
A Closer Look at BioAge Labs: Legal Challenges Ahead

Updated Category News Views 206

Understanding the Legal Landscape of BioAge Labs Investors in BioAge Labs, Inc. have faced new uncertainties as the clinical-stage biopharmaceutical company becomes entangled in legal challenges. As the firm moves forward in its mission to develop innovative therapies aimed at combating metabolic diseases, significant developments have emerged that every investor should...

Continue Reading
Celebrating the Fusion of Science and Cinema at Starmus 2025

Updated Category News Views 202

Fusion of Science and Cinema at Starmus Festival The Starmus Festival is a unique event that intertwines science and art, culminating in extraordinary dialogues and presentations. Recently, renowned director Christopher Nolan was awarded the prestigious Stephen Hawking Medal for Science Communication during this remarkable celebration. This accolade is not just an honor...

Continue Reading
Millicom Takes Steps to Enhance Transparency in Holdings

Updated Category News Views 82

Millicom Takes Steps to Enhance Transparency in Holdings Millicom International Cellular S.A., commonly recognized as Tigo, is making significant strides in open communication and compliance by submitting regulatory notifications regarding major shareholder holdings. This initiative reinforces their commitment to transparency and regulatory excellence in the ever-evolving...

Continue Reading